Introducing an innovative product from Shanghai Lizhuo Pharmaceutical Technology Co., Ltd., a leading manufacturer, supplier, and factory based in China. We are proud to present our latest creation: (s)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4.6-diaMine. This exceptional compound is the result of extensive research and development, combining the expertise of our dedicated team of scientists and cutting-edge technology. (s)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4.6-diaMine represents a breakthrough in pharmaceutical solutions, offering immense potential for various applications. With its unique molecular structure, this product exhibits remarkable biological activity and therapeutic properties. Its versatility makes it an invaluable building block for drug discovery, particularly in the field of oncology. Additionally, it holds promise for research in inflammation, cardiovascular diseases, and neurological disorders. Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. is committed to providing the highest quality products that meet global standards. Our state-of-the-art facilities and stringent quality control ensure the purity, consistency, and stability of this product. Whether you are a pharmaceutical company, research institution, or academic organization, our (s)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4.6-diaMine can be a valuable addition to your research and development. Choose Shanghai Lizhuo Pharmaceutical Technology Co., Ltd. as your trusted partner for all your pharmaceutical needs. Contact us today and unlock the potential of (s)-N4-(3-chloro-4-fluorophenyl)-7-(tetrahydrofuran-3-yloxy)quinazoline-4.6-diaMine in advancing scientific breakthroughs and improving global healthcare.